Tag: RSV
Dr Reddy’s & Sanofi Healthcare expand partnership to launch Beyfortus, a...
Beyfortus® (nirsevimab) is the first monoclonal antibody approved to protect all infants born during or entering their 1st Respiratory Syncytial Virus (RSV) season
Moderna receives U.S. FDA approval for RSV Vaccine mRESVIA
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
GSK’s Arexvy label expansion will intensify competition with Pfizer’s Abrysvo in...
The European Medicines Agency (EMA) recently accepted the company’s regulatory application to expand the use of Arexvy and a decision is anticipated in H2 2024
AstraZeneca India gets CDSCO approval for Palivizumab, a preventive therapy for...
In India, Respiratory Syncytial Virus is the most common cause of hospitalization in children <1 years old